M-J Lai

Dr. M-J Lai


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2022 in Nanomaterials
Verified
Journal Article
Open access
PDF file
MLM-J Lai
M-J Lai
YHYue-Wern Huang
Yue-Wern Huang
HCHsuan-Chun Chen
Hsuan-Chun Chen
LTLi-I Tsao
Li-I Tsao
CCChih-Fang Chang Chien
Chih-Fang Chang Chien
BLBetty Revon Liu
Betty Revon Liu
Metal and metal oxide nanoparticles, including copper nanoparticles (CuNPs), display antimicrobial activities and are regarded as promising microorganism inhibitors. Here, we explored the antimicrobial activity of CuNPs in Escherichia coli (E. coli) using two particle sizes (20 and 60 nm) and five concentrations (1, 5, 10, 50 and 100 μg/mL). The result showed a concentration-dependent trend of bactericidal activities for both size groups, with 20 nm particles more effective than 60 nm particles at low concentrations. The membrane disruption caused by CuNPs was confirmed by electron microscopy, PI staining and protein leaking analysis. However, the results of reactive oxygen species generation and genomic DNA damage revealed that the size and concentration of CuNPs were factors affecting the induction of multiple bactericidal mechanisms simultaneously on different scales. Further results of annexin V-PI staining supported this hypothesis by showing the shifting composition of the early-, late- and non-apoptotic dead cells across the CuNP groups. Many CuNP treatment groups were rescued when four mammalian modulators—wortmannin, necrosulfonamide, Z-VAD-FMK, and SBI-0206965—were applied separately. The results suggest the possible existence of bacterial programmed cell death pathways in E. coli which could be triggered by CuNP treatments.

8 June 2024
Verified
Book Chapter
Open access
PDF file
MLM-J Lai
M-J Lai
YHYue-Wern Huang
Yue-Wern Huang
JWJonathan Wijaya
Jonathan Wijaya
BLBetty Revon Liu
Betty Revon Liu
Copper, a reddish and ubiquitous material in the world, possesses malleable and conductive properties that render copper and its alloys indispensable in vertical integration manufacturing. With advancements in nanotechnology and nanomaterials in recent decades, copper and its related nanoparticles have been engineered. Their applications include engineering, material science, photo/electro-catalysis, biomedical drug delivery, agriculture, and antipathogen microbicides. Here, we studied the differing toxicity effects of two sizes of copper nanoparticles (CuNPs), recognized for their potent bactericidal properties. Concentration-dependent effects of both 20 and 60nm CuNPs were significant in Escherichia coli (E. coli), Acinetobacter baumannii (A. baumannii), and Staphylococcus aureus (S. aureus). Sodium dodecyl sulfate, the dispersant of nanoparticles, caused the synergy effects with CuNPs in A. baumannii and S. aureus but not in E. coli. Four modulators were added to CuNP-treated bacteria. By these modulator treatments, programmed cell death was found in E. coli, A. baumannii, and S. aureus. By the BLAST search, caspase-related proteins were commonly identified in gut bacteria and A. baumannii but not in S. aureus. Furthermore, many proteins from E. coli, A. baumannii, and S. aureus were found to harbor the ULK1-catalytic domain. In short, CuNPs can be potent therapeutic agents against bacterial infections.

16 May 2025 in Journal of Visualized Experiments
Verified
Journal Article
Closed access
PDF file
MLM-J Lai
M-J Lai
JWJonathan Wijaya
Jonathan Wijaya
YHYue-Wern Huang
Yue-Wern Huang
HLHolly Liu
Holly Liu
BLBetty Revon Liu
Betty Revon Liu
Recently, concerns over multidrug-resistant pathogens and incurable infections have increased due to the overuse and misuse of antibiotics. Nanomaterials, such as metallic and metallic oxide nanoparticles, have gained popularity in the biomedical field as potential new strategies to combat multidrug-resistant pathogens. This study investigated the use of copper nanoparticles (CuNPs) as a bactericide against three common hospital-acquired opportunistic pathogens-Escherichia coli (E. coli), Acinetobacter baumannii (A. baumannii), and Staphylococcus aureus (S. aureus)-which are increasingly developing drug resistance. Detailed protocols are presented for synthesizing CuNPs of two sizes (20 nm and 60 nm) and evaluating their bactericidal efficacy through colony assays. The mechanisms of antimicrobial action underlying CuNPs were explored by assessing changes in reactive oxygen species production. Additionally, four modulators that inhibit human protein functions were applied to study the potential involvement of programmed cell death (PCD) pathways in bacterial killing. Through this approach, the potential emergence of copper-resistant strains is suggested, building on research into copper homeostasis proteins, including copper-dependent transcriptional regulators. These findings provide a comprehensive methodology for studying the bactericidal effects of CuNPs and their potential role in addressing antibiotic resistance.

21 August 2026
Verified
Book Chapter
Open access
PDF file
MLM-J Lai
M-J Lai
TCTing-Yu Chang
Ting-Yu Chang
CSCiou-Nan Syue
Ciou-Nan Syue
BLBetty Revon Liu
Betty Revon Liu
Death is an inevitable step in life; however, recent research into the phenomenon of anastasis has fundamentally challenged the traditional dogma that programmed cell death is an irreversible process, revealing a remarkable survival mechanism in which cells recover from the brink of apoptosis. Our study explored the physiological transitions and adaptive advantages gained during anastasis-like recovery by subjecting cellular models to heat shock stress to trigger apoptotic signaling. Upon the removal of the thermal stressor, we observed that the surviving cell population did not merely revert to its baseline physiological state but instead exhibited significantly enhanced cellular robustness and heightened metabolic plasticity. Our findings suggest that the process of anastasis-like recovery acts as a “stress-priming” event, in which the transient activation of heat shock proteins and DNA repair pathways during the recovery phase confers acquired resistance to subsequent lethal insults. In short, our findings suggest that anastasis is possibly not only a passive recovery process but also a proactive survival strategy that enhances competitive fitness, potentially offering new perspectives on tissue regeneration and the mechanisms by which cells adapt to extreme environmental fluctuations.

16 May 2025
Verified
Dataset
Closed access
PDF file
MLM-J Lai
M-J Lai
JWJonathan Wijaya
Jonathan Wijaya
YHYue-Wern Huang
Yue-Wern Huang
HLHolly Liu
Holly Liu
BLBetty Revon Liu
Betty Revon Liu
Recently, concerns over multidrug-resistant pathogens and incurable infections have increased due to the overuse and misuse of antibiotics. Nanomaterials, such as metallic and metallic oxide nanoparticles, have gained popularity in the biomedical field as potential new strategies to combat multidrug-resistant pathogens. This study investigated the use of copper nanoparticles (CuNPs) as a bactericide against three common hospital-acquired opportunistic pathogens-Escherichia coli (E. coli), Acinetobacter baumannii (A. baumannii), and Staphylococcus aureus (S. aureus)-which are increasingly developing drug resistance. Detailed protocols are presented for synthesizing CuNPs of two sizes (20 nm and 60 nm) and evaluating their bactericidal efficacy through colony assays. The mechanisms of antimicrobial action underlying CuNPs were explored by assessing changes in reactive oxygen species production. Additionally, four modulators that inhibit human protein functions were applied to study the potential involvement of programmed cell death (PCD) pathways in bacterial killing. Through this approach, the potential emergence of copper-resistant strains is suggested, building on research into copper homeostasis proteins, including copper-dependent transcriptional regulators. These findings provide a comprehensive methodology for studying the bactericidal effects of CuNPs and their potential role in addressing antibiotic resistance.